Regeneron Pharmaceuticals's CEO Salary

Regeneron Pharmaceuticals's CEO salary and other executives compensation in 2025 was as follows:

Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply at Regeneron Pharmaceuticals, received a total compensation of $8.78 M in 2025.
Andrew J. Murphy, Ph.D. Executive Vice President, Co-Chief Scientific Officer at Regeneron Pharmaceuticals, received a total compensation of $8.48 M in 2025.
Joseph J. LaRosa Executive Vice President, General Counsel and Secretary at Regeneron Pharmaceuticals, received a total compensation of $7.46 M in 2025.
Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer at Regeneron Pharmaceuticals, received a total compensation of $7.28 M in 2025.
Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer at Regeneron Pharmaceuticals, received a total compensation of $6.99 M in 2025.
George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer at Regeneron Pharmaceuticals, received a total compensation of $6.95 M in 2025.

CEO/ Executive salary tells one part of the story. Explore Employee Count Trend, Revenue per Employee, and Profit per Employee to understand workforce scale, and employee productivity.

Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply

Per Year
Per Month
Per Week
Per Day

Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply, at Regeneron Pharmaceuticals, received $983.38 K in base salary, $2.70 M in stock award, and $82.21 K in other compensation, making $8.78 M in total compensation in 2025.

The total compensation was +1.45% up from the previous year, 2024.

Andrew J. Murphy, Ph.D. Executive Vice President, Co-Chief Scientific Officer

Per Year
Per Month
Per Week
Per Day

Andrew J. Murphy, Ph.D. Executive Vice President, Co-Chief Scientific Officer, at Regeneron Pharmaceuticals, received $819.67 K in base salary, $2.70 M in stock award, and $92.80 K in other compensation, making $8.48 M in total compensation in 2025.

The total compensation was +1.36% up from the previous year, 2024.

Joseph J. LaRosa Executive Vice President, General Counsel and Secretary

Per Year
Per Month
Per Week
Per Day

Joseph J. LaRosa Executive Vice President, General Counsel and Secretary, at Regeneron Pharmaceuticals, received $916.06 K in base salary, $1.80 M in stock award, and $132.74 K in other compensation, making $7.46 M in total compensation in 2025.

Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer

Per Year
Per Month
Per Week
Per Day

Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer, at Regeneron Pharmaceuticals, received $1.98 M in base salary, - in stock award, and $1.62 M in other compensation, making $7.28 M in total compensation in 2025.

The total compensation was +6.71% up from the previous year, 2024.

Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer

Per Year
Per Month
Per Week
Per Day

Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer, at Regeneron Pharmaceuticals, received $725.00 K in base salary, $2.20 M in stock award, and $39.62 K in other compensation, making $6.99 M in total compensation in 2025.

The total compensation was +11.44% up from the previous year, 2024.

George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer

Per Year
Per Month
Per Week
Per Day

George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer, at Regeneron Pharmaceuticals, received $1.98 M in base salary, - in stock award, and $1.29 M in other compensation, making $6.95 M in total compensation in 2025.

The total compensation was +2.25% up from the previous year, 2024.

Executive	2025	2024	2023
Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply	$8.78 M	••••••••	••••••••
Base Salary	$983.38 K	••••••••	••••••••
Incentive Plan Compensation	$965.19 K	••••••••	••••••••
All Other Compensation	$82.21 K	••••••••	••••••••
Stock Award	$2.70 M	••••••••	••••••••
Andrew J. Murphy, Ph.D. Executive Vice President, Co-Chief Scientific Officer	$8.48 M	••••••••	••••••••
Base Salary	$819.67 K	••••••••	••••••••
Incentive Plan Compensation	$815.16 K	••••••••	••••••••
All Other Compensation	$92.80 K	••••••••	••••••••
Stock Award	$2.70 M	••••••••	••••••••
Joseph J. LaRosa Executive Vice President, General Counsel and Secretary	$7.46 M	••••••••	••••••••
Base Salary	$916.06 K	••••••••	••••••••
Incentive Plan Compensation	$911.02 K	••••••••	••••••••
All Other Compensation	$132.74 K	••••••••	••••••••
Stock Award	$1.80 M	••••••••	••••••••
Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer	$7.28 M	••••••••	••••••••
Base Salary	$1.98 M	••••••••	••••••••
Incentive Plan Compensation	$3.68 M	••••••••	••••••••
All Other Compensation	$1.62 M	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer	$6.99 M	••••••••	••••••••
Base Salary	$725.00 K	••••••••	••••••••
Incentive Plan Compensation	$721.01 K	••••••••	••••••••
All Other Compensation	$39.62 K	••••••••	••••••••
Stock Award	$2.20 M	••••••••	••••••••
George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer	$6.95 M	••••••••	••••••••
Base Salary	$1.98 M	••••••••	••••••••
Incentive Plan Compensation	$3.68 M	••••••••	••••••••
All Other Compensation	$1.29 M	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Andrew J. Murphy, Ph.D. Executive Vice President, Research	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••
Robert E. Landry (retired) Former Executive Vice President, Finance and Chief Financial Officer	-	••••••••	••••••••
Base Salary	-	••••••••	••••••••
Incentive Plan Compensation	-	••••••••	••••••••
All Other Compensation	-	••••••••	••••••••
Stock Award	-	••••••••	••••••••

To access the data, Sign up for free

Submit feedback to Bullfincher

Regeneron Pharmaceuticals's CEO Salary

Daniel P. Van Plew Executive Vice President and General Manager, Industrial Operations and Product Supply

Andrew J. Murphy, Ph.D. Executive Vice President, Co-Chief Scientific Officer

Joseph J. LaRosa Executive Vice President, General Counsel and Secretary

Leonard S. Schleifer, M.D., Ph.D. Board co-Chair, President and Chief Executive Officer

Christopher Fenimore Executive Vice President, Finance and Chief Financial Officer

George D. Yancopoulos, M.D., Ph.D. Board co-Chair, President and Chief Scientific Officer

Executive Compensation Summary Table

Related

People Also Search For

Submit feedback to Bullfincher